Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

HKG:1066 Revenue

In the year 2025, Shandong Weigao Group Medical Polymer Company had annual revenue of 13.39B CNY with 2.31% growth. Shandong Weigao Group Medical Polymer Company had revenue of 6.74B in the half year ending December 31, 2025, with 6.52% growth.

• Revenue: 13.39B CNY
• Revenue Growth: +2.31%
• P/S Ratio: 1.39
• Revenue / Employee: 1.02M CNY
• Employees: 13,063
• Market Cap: 20.74B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.39B	301.82M	2.31%
Dec 31, 2024	13.09B	-142.38M	-1.08%
Dec 31, 2023	13.23B	-518.02M	-3.77%
Dec 31, 2022	13.75B	538.53M	4.08%
Dec 31, 2021	13.21B	1.59B	13.65%